Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT00791518
Eligibility Criteria:
Inclusion Criteria:
* Cigarette smoking history-Current or ex-smokers (defined as stopped smoking for at least three months prior to the study visit)
* Established history of COPD as diagnosed by a physician
* Regular use (prescribed for use every day) of only one long-acting bronchodilator greater than or equal to one month before the study visit
* Ability to read, comprehend, and record information in the English language
Exclusion Criteria:
* Currently active asthma (receiving asthma therapy and or having asthma symptoms)
* Use of ipratropium/albuterol combination products greater than three times per day, use of inhaled corticosteroids, use of inhaled corticosteroid/long-acting beta-agonist combinations, theophylline preparations, or oral beta agonists within 3 months prior to the study visit
* Previous lung surgery
* Other respiratory disorders other than COPD
* Current alcohol, illegal drug, or solvent abuse
* Females with a positive urine pregnancy test at the study visit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT00791518
Study Brief:
Protocol Section:
NCT00791518